PI
CVS icon

PEAK6 Investments’s CVS Health CVS Stock Holding History

PEAK6 Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$19M Buy
301,400
+123,100
+69% +$7.18M 0.04% 355
2024
Q2 		$10.5M Buy
178,300
+136,700
+329% +$8.55M 0.03% 470
2024
Q1 		$3.32M Sell
41,600
-94,700
-69% -$7.23M 0.01% 1082
2023
Q4 		$10.8M Buy
136,300
+69,500
+104% +$4.95M 0.04% 449
2023
Q3 		$4.66M Buy
66,800
+5,500
+9% +$390K 0.02% 754
2023
Q2 		$4.24M Sell
61,300
-381,800
-86% -$27.2M 0.02% 737
2023
Q1 		$32.9M Buy
443,100
+378,300
+584% +$31.7M 0.16% 106
2022
Q4 		$6.04M Buy
64,800
+22,000
+51% +$2.12M 0.03% 607
2022
Q3 		$4.08M Sell
42,800
-333,000
-89% -$33M 0.02% 964
2022
Q2 		$33.4M Buy
375,800
+219,600
+141% +$21.4M 0.06% 286
2022
Q1 		$15.8M Sell
156,200
-157,100
-50% -$16.5M 0.03% 498
2021
Q4 		$32.3M Sell
313,300
-106,400
-25% -$9.83M 0.07% 271
2021
Q3 		$35.6M Sell
419,700
-112,836
-21% -$9.45M 0.08% 216
2021
Q2 		$47.2M Buy
532,536
+126,636
+31% +$10.4M 0.11% 155
2021
Q1 		$30.5M Sell
405,900
-591,000
-59% -$43M 0.07% 233
2020
Q4 		$68.1M Sell
996,900
-116,000
-10% -$7.54M 0.14% 125
2020
Q3 		$65M Buy
1,112,900
+452,500
+69% +$28.2M 0.16% 114
2020
Q2 		$42.9M Sell
660,400
-3,500
-0.5% -$220K 0.15% 129
2020
Q1 		$39.4M Sell
663,900
-737,800
-53% -$49.3M 0.23% 70
2019
Q4 		$104M Buy
1,401,700
+118,800
+9% +$8.34M 0.54% 27
2019
Q3 		$80.3M Sell
1,282,900
-189,500
-13% -$11.2M 0.5% 19
2019
Q2 		$80.2M Sell
1,472,400
-64,900
-4% -$3.49M 0.53% 16
2019
Q1 		$82.9M Buy
1,537,300
+1,267,400
+470% +$78.2M 0.49% 24
2018
Q4 		$17.7M Sell
269,900
-95,800
-26% -$7.15M 0.11% 172
2018
Q3 		$28.8M Buy
+365,700
New +$26.1M 0.13% 150

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's CVS Position: Q3 2024 in Review

PEAK6 Investments increased its CVS Health (CVS) stake by 255% in Q3 2024, buying an estimated $12.3M and bringing the position to 292,920 shares worth $18.4M. The position accounts for 0.04% of the portfolio, ranked #360.

PEAK6 Investments first reported a position in CVS in Q4 2018 and has held it in 17 quarters since. The position peaked at $41.1M in Q1 2019. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • PEAK6 Investments held 292,920 shares of CVS Health worth $18.4M as of Q3 2024.
  • PEAK6 Investments bought 210,350 CVS Health shares in Q3 2024, an estimated $12.3M.
  • CVS Health made up 0.04% of PEAK6 Investments's portfolio in Q3 2024, its #360 holding.
  • PEAK6 Investments first reported a position in CVS Health in Q4 2018 and has held it in 17 quarters since.
  • PEAK6 Investments's CVS Health position peaked at $41.1M in Q1 2019.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.